Healthcare deals: Live updates on mergers and acquisitions - Modern Healthcare

• Helus Pharma will participate in the Morgan Stanley Healthcare Conference, where Michael Halstead will give a fireside chat on September 16. • The chat will be webcast live at 8:30 a.m. EDT and a replay will be available on Helus Pharma's investor relations website.

• The FDA has expanded its approval of a Bayer lung cancer drug, although the specific details of the expansion are not provided in the given information. • The announcement is part of a broader set of biotech news that includes updates on UniQure and an AI effort to manage heart failure.

• The Respiratory Illnesses Data Channel provides information on COVID-19, flu, and RSV activity across the United States. • The channel offers data on the level of respiratory illness activity in different communities, allowing users to track local and national trends.

• The Indian Medical Association has requested intervention from Prime Minister Narendra Modi and the National Medical Commission regarding long working hours and harassment faced by doctors, which is causing severe burnout. • WHO Director-General Tedros Adhanom has praised India's progress in primary healthcare, maternal and child health, and non-communicable disease prevention and control, during a meeting with Union Health Minister J P Nadda.

• A new wave of illegal fruity vapes has emerged, posing health risks to users, particularly among youth and young adults. • Researchers and healthcare providers are noting an increasing trend of children being prescribed GLP-1s, a type of medication typically used to treat type 2 diabetes and obesity.

• The Centers for Disease Control and Prevention (CDC) maintains a list of current outbreaks and provides outbreak-related resources through its Health Alert Network (HAN). • The CDC's Morbidity and Mortality Weekly Report (MMWR) Series is a key resource for information on public health incidents, including outbreaks linked to animals and animal products in the US.

• A global COVID-19 tracker is now available, providing data on cases and deaths by country, region, and income level, as well as policy responses to the pandemic. • The tracker includes information on vaccine eligibility, with partial availability defined as availability for certain groups such as key workers, non-elderly clinically vulnerable groups, and elderly groups.

• The 2026 Bundibugyo Ebola outbreak has reached 5,794 confirmed cases and 2,786 deaths. • The World Health Organization currently recommends using the licensed Ervebo vaccine only within research protocols because there is insufficient evidence it protects humans against the Bundibugyo virus.

• NanoViricides, Inc. registered a successful Phase II clinical trial for its NV-387 oral gummies designed to treat Ebola viruses in the Democratic Republic of the Congo. • Professor Patrick de Marie Chimusa Katoto led the trial and expects dosing to begin within one to two weeks.

• The CEO of Helus Pharma will participate in a live webcast on September 14 during the H.C. Wainwright conference in New York. • The presentation begins at 9 a.m. EDT and will be available for replay on the company's Events & Presentations page.

• The FDA approved seven new drugs in August 2026 across various medical fields. • These approvals cover treatments for sleep disorders, Alzheimer's disease diagnostics, oncology, rare diseases, autoimmune conditions, and hematology.